ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Philips extends leadership in virtually helium-free MRI with more than 1,000 systems installed, expanding patient access worldwide

February 28, 2024

At #ECR2024, company also debuting Europe’s first mobile virtually helium-free MRI system

Amsterdam, the Netherlands and Vienna, Austria – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced a significant milestone as it expands access to virtually helium-free [1] MRI to more patients in more places, with more than 1,000 systems now installed worldwide. As healthcare providers strive to deliver high-quality care to patients, at #ECR2024 Philips is partnering with its customers to improve productivity and access to more sustainable healthcare.

Philips BlueSeal magnet is the industry's first 1.5T fully sealed magnet and requires only 0.5% of the helium of a conventional Philips MR system. By dramatically easing installation requirements and addressing helium scarcity, the Philips BlueSeal 1.5T magnet is helping more patients in diverse locations benefit from a technology that plays an essential role in diagnosing many of the world’s most prevalent diseases.

Philips BlueSeal technology is expanding the reach of MRI to places where it was previously too difficult to install and maintain, including remote and isolated locations, and those prone to tropical storms, earthquakes, and other geographical obstacles. With a magnet that’s 900kg lighter than a traditional system [2] and doesn’t require a quench pipe – required for traditional MR systems to safely expel their large volume of helium out of a building quickly in case of an emergency – Philips MR systems equipped with BlueSeal magnets can be installed in places that were previously unthinkable.

“We wanted to set up the MRI in the basement of a building in the middle of the city center to provide better access to care for our patients. Not having a quench pipe to expel helium out of the building in the event of an emergency was very important to us due to the location of the MRI system,” said Hiroyuki SUGAYA, M.D., President, Tokyo Sports & Orthopedic Clinic, Tokyo, Japan. “We also needed an MRI system that would be a good financial investment, significantly reducing construction costs and reducing the need to refill helium.”

First installed in 2018, Philips’ BlueSeal magnet is a proven and reliable technology that is rapidly reshaping patient access to MRI worldwide. Patients on remote island areas in Indonesia and Thailand, as well those in areas at risk of earthquakes and volcanoes in Iceland and Japan, are already benefiting from the technology.

Philips is now bringing its innovation in virtually helium-free MRI to a mobile truck, with the first BlueSeal MR mobile unit [3] developed in Europe for Denmark-based Agito Medical Imaging making its debut at #ECR2024. MR systems equipped with Philips’ BlueSeal magnet technology have saved more than 1.9 million liters of helium since 2018 [4].

“The rapid global adoption of our virtually helium-free MR technology is a strong example of how we are improving the lives of patients, expanding access to cutting-edge imaging technology,” said Ruud Zwerink, Business Leader of MR at Philips. “With over 1,000 systems installed globally, our proven technology is bringing MRI closer to patients wherever it’s needed, as well as providing an answer to growing concerns of helium supply chain disruptions.”

[1] Systems contain 7 liters of helium, fully sealed, no helium can leave the system.
[2] Compared to Philips earlier (non-BlueSeal) Ingenia 1.5T ZBO magnet.
[3] BlueSeal mobile 1.5T is considered a work in progress and is not CE marked and not available for sale.  
[4] The amount of liquid helium saved is calculated compared to a classic magnet with 1,500 liters of helium.

For further information, please contact:

Kathy O’Reilly
Philips Global External Relations
Tel.: +1 978-221-8919
E-mail: kathy.oreilly@philips.com

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring, and enterprise informatics, as well as in personal health. Philips generated 2023 sales of EUR 18.2 billion and employs approximately 69,700 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.

Attachments


Primary Logo

Recent Quotes

View More
Symbol Price Change (%)
AMZN  229.25
+2.28 (1.00%)
AAPL  269.00
+0.19 (0.07%)
AMD  258.01
-1.66 (-0.64%)
BAC  52.87
-0.15 (-0.28%)
GOOG  268.43
-1.50 (-0.56%)
META  751.44
+0.62 (0.08%)
MSFT  542.07
+10.55 (1.98%)
NVDA  201.03
+9.54 (4.98%)
ORCL  280.83
-0.57 (-0.20%)
TSLA  460.55
+8.13 (1.80%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.